The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

As medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings account (if you have one). There is no coverage for obesity management ...

Starting in mid-2022, celebrities and influencers began posting about their weight loss journeys using GLP-1 drugs, drawing millions of views on social media. The result was free publicity for ...

I even managed to have a few bursts at running,” she said. Dee said the weight loss has caused her health to improve significantly. She sleeps better, has more energy throughout the day and her mood ...

When considering the top stocks, funds and trusts to invest in, are the pharmaceutical and biotech companies behind weight-loss drugs worth a look? “In 2021, Lisa Chen, a software engineer ...

Aqua Sculpt suppresses the appetite and enhances digestion to maintain a healthy body weight. Weight loss supplements have become the need of the hour as the number of obese people is increasing day ...